Athira Pharma, Inc. (41) | Change of Control Agreements (8)
Recent Contracts
-
Change in Control and Severance Agreement between the Registrant and Kevin Church
(Filed With SEC on March 28, 2022)
-
Amended and Restated Change in Control and Severance Agreement between the Company and Mark Litton, Ph.D
(Filed With SEC on January 31, 2022)
-
Change in Control and Severance Agreement between the Registrant and Rachel Lenington
(Filed With SEC on August 16, 2021)
-
Change in Control and Severance Agreement between the Registrant and Mark Worthington
(Filed With SEC on August 16, 2021)
-
Change in Control and Severance Agreement between the Registrant and Hans Moebius, Ph.D
(Filed With SEC on September 14, 2020)
-
Change in Control and Severance Agreement between the Registrant and Leen Kawas, Ph.D
(Filed With SEC on September 9, 2020)
-
Change in Control and Severance Agreement between the Registrant and Mark Litton, Ph.D
(Filed With SEC on September 9, 2020)
-
Change in Control and Severance Agreement between the Registrant and Glenna Mileson
(Filed With SEC on September 9, 2020)